Product
COVID-19 vaccine HIPRA 40
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Phase I/IIa Study to Evaluate Safety and Immunogenicity of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy VolunteersStatus: Completed, Estimated PCD: 2021-09-30